AIxMed Inc. proudly introduces AIxURO, an artificial Intelligent software to solve the most challenging problems in urine cytology by integrating advanced machine learning and computer vision technology. This cutting-edge software features the risk stratification of identifying 5-10 rare bladder cancer cells from tens of thousands of cells distributed in 3D urine slides. With a simple urine test, AIxURO provides insightful quantitative information to support physicians in surveillance of bladder cancer.

1. Urine cytology is helpful for an initial evaluation and in a follow-up setting for patients with bladder cancer. It is simple, non-invasive, cost-effective, and could reduce the risk of overuse of cystoscopy.
2. AIxURO, AI software classifies atypical UC candidate cells with risk stratification and effectively assists cytopathologists in reporting urine cytology.